Evidence map›Paper›PMID 37550201›Full record

ArticleZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi2023

[Second allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning and donor changes in relapsed hematological malignancies after the first allogeneic transplant].

Y Q Zhao, Y Z Song, Z H Li, F Yang, T Xu, F F Li, D F Yang, T Wu

Open access · greenAbstract readEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Second allogeneic transplants in children: twelve years of experienceBiomedica : revista del Instituto Nacional de Salud · 2026
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Y Q ZhaoDepartment of Bone Marrow Transplantation, Beijing Gobroad Boren Hospital, Beijing 100070, China.
Y Z SongDepartment of Bone Marrow Transplantation, Beijing Gobroad Boren Hospital, Beijing 100070, China.
Z H LiDepartment of Bone Marrow Transplantation, Beijing Gobroad Boren Hospital, Beijing 100070, China.
F YangDepartment of Bone Marrow Transplantation, Beijing Gobroad Boren Hospital, Beijing 100070, China.
T XuDepartment of Bone Marrow Transplantation, Beijing Gobroad Boren Hospital, Beijing 100070, China.
F F LiDepartment of Bone Marrow Transplantation, Beijing Gobroad Boren Hospital, Beijing 100070, China.
D F YangDepartment of Bone Marrow Transplantation, Beijing Gobroad Boren Hospital, Beijing 100070, China.
T WuDepartment of Bone Marrow Transplantation, Beijing Gobroad Boren Hospital, Beijing 100070, China.
Beijing Fengtai Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Graft vs Host DiseaseHematologic NeoplasmsHematopoietic Stem Cell TransplantationAdultBusulfanChronic DiseaseHumansNeoplasm Recurrence, LocalRetrospective StudiesTransplantation ConditioningTransplantation, HomologousUnrelated DonorsBusulfanDonorHematological malignancyReduced-intensity conditioningSecond allogeneic hematopoietic stem cell transplantation

Identifiers

PMID37550201
PMCPMC10450545
OpenAlexW4385680937

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.